Sotera Health Company SHC
18.34
(0.11)
(0.60%)
as of 25 Sep
- Market cap
- $5.3B
- P/E
- 32.1×
Follow SHC
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 4,648.15 | 4,648.15 | 0.00 | 56.07 | 0.00 | 93.06 | 91.20 | 65.33 |
P/S ratio |
— | 7.32 | 7.32 | 8.50 | 7.06 | 2.32 | 4.49 | 3.52 | 4.30 |
P/FCF ratio |
— | 37.18 | 37.18 | 103.69 | 36.66 | 24.41 | 0.00 | 85.79 | 33.58 |
P/Operating CF |
— | 126.66 | 126.66 | 318.39 | 99.11 | 22.89 | 41.61 | 69.43 | 48.58 |
P/B ratio |
— | 0.00 | 0.00 | 15.30 | 11.22 | 6.66 | 10.61 | 9.55 | 8.27 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 10.94 | 10.94 | 10.66 | 8.87 | 3.92 | 6.34 | 5.37 | 5.93 |
EV/EBITDA |
— | 24.81 | 24.81 | 24.15 | 19.97 | 9.62 | 15.00 | 12.61 | 13.68 |
EV/Operating CF |
— | 35.18 | 35.18 | 72.34 | 29.35 | 14.17 | (45.04) | 26.35 | 24.02 |
EV/FCF |
— | 55.56 | 55.56 | 130.05 | 46.07 | 41.20 | (18.34) | 131.01 | 46.23 |
Quick Ratio |
— | 1.50 | 1.31 | 1.54 | 1.36 | 0.67 | 1.97 | 2.23 | 1.98 |
Current Ratio |
— | 2.18 | 2.04 | 2.24 | 2.15 | 0.81 | 2.42 | 2.75 | 2.46 |
Net Debt/EBITDA |
— | 7.51 | 8.22 | 4.90 | 4.08 | 3.92 | 4.39 | 4.35 | 3.74 |
Debt/Assets |
0.00% | 82.57% | 110.32% | 67.75% | 64.33% | 64.19% | 71.83% | 75.47% | 68.48% |
Debt/Equity |
— | 49.16 | (4.44) | 4.12 | 3.06 | 5.71 | 5.07 | 5.73 | 3.69 |
Asset Turnover |
— | 0.55 | 0.29 | 0.31 | 0.34 | 0.34 | 0.34 | 0.35 | 0.37 |
Operating CF/Net income |
— | (20.37) | (7.15) | (3.12) | 2.41 | (1.19) | (2.89) | 5.06 | 3.68 |
Capex/Depreciation |
— | (0.36) | (0.37) | (0.34) | (0.65) | (1.13) | (1.29) | (1.05) | (0.97) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 1.96% | 7.00% | 41.40% | 22.46% | (49.89%) | 12.87% | 10.45% | 15.42% | |
| — | (0.43%) | (0.79%) | (1.45%) | 4.21% | (7.91%) | 1.64% | 1.43% | 2.46% | |
ROIC |
— | 2.31% | 5.35% | 5.79% | 7.06% | 7.94% | 7.23% | 7.61% | 9.07% |
Return on Tangible Assets |
— | (0.78%) | (2.94%) | (4.92%) | 13.99% | (37.19%) | 4.01% | 3.23% | 5.22% |
Average Days of Receivables |
— | 57.65 | 46.56 | 50.64 | 44.21 | 47.49 | 53.37 | 48.75 | 46.21 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 17.87% | 18.95% | 21.82% | 21.27% | 24.48% | 22.56% | 22.05% | 21.72% |
Intangible Assets out of Total Assets |
0.00 | 0.66 | 0.67 | 0.64 | 0.62 | 0.51 | 0.49 | 0.46 | 0.43 |
Share Based Compensation of Revenue |
— | 0.93% | 0.88% | 1.34% | 1.49% | 2.11% | 3.07% | 3.34% | 2.65% |
Graham Net Nets |
— | 0.05 | 0.05 | (0.29) | (0.28) | (0.91) | (0.45) | (0.55) | (0.41) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 4.45 | 0.00 | 2.53 | 2.20 | 3.60 |
Earnings Yield |
— | 0.02% | 0.02% | (0.53%) | 1.78% | (9.96%) | 1.07% | 1.10% | 1.53% |
Free Cash Flow Yield |
— | 2.69% | 2.69% | 0.96% | 2.73% | 4.10% | (7.71%) | 1.17% | 2.98% |
Revenue per Share |
— | 3.21 | 3.35 | 3.44 | 3.34 | 3.58 | 3.73 | 3.89 | 4.10 |
Operating CF per Share |
— | 0.51 | 0.64 | 0.51 | 1.01 | 0.99 | (0.53) | 0.79 | 1.01 |
Capex per Share |
— | (0.31) | (0.25) | (0.23) | (0.37) | (0.65) | (0.76) | (0.63) | (0.49) |
Free Cash Flow per Share |
— | 0.20 | 0.39 | 0.28 | 0.64 | 0.34 | (1.29) | 0.16 | 0.53 |
Cash per Share |
— | 0.42 | 0.27 | 0.43 | 0.38 | 1.41 | 1.07 | 0.99 | 1.22 |
Shareholders Equity per Share |
— | 0.20 | (2.76) | 1.91 | 2.10 | 1.25 | 1.58 | 1.43 | 2.13 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.20 | (2.76) | 1.91 | 2.10 | 1.25 | 1.58 | 1.43 | 2.13 |
Free Cash Flow |
— | 46.95 | 91.78 | 67.08 | 179.38 | 95.58 | (362.71) | 45.09 | 149.18 |
Working Capital |
— | 169.49 | 128.36 | 174.42 | 184.80 | (146.56) | 326.59 | 335.04 | 363.83 |
Capital Expenditures |
— | (72.61) | (57.26) | (53.51) | (102.16) | (182.38) | (214.97) | (179.07) | (138.02) |
Net Current Asset Value |
— | (2,350.23) | (2,969.45) | (1,991.69) | (1,857.44) | (2,122.46) | (2,129.44) | (2,140.70) | (2,043.74) |
EV/EBIT |
— | 0.00 | 0.00 | 42.34 | 32.19 | 15.86 | 24.05 | 19.85 | 19.05 |
Capex to Sales |
— | 0.10 | 0.07 | 0.07 | 0.11 | 0.18 | 0.20 | 0.16 | 0.12 |
Net Profit Margin |
— | (0.79%) | (2.68%) | (4.72%) | 12.55% | (23.27%) | 4.87% | 4.03% | 6.70% |
Price to Operating Income |
— | 0.00 | 0.00 | 33.76 | 25.61 | 9.39 | 17.01 | 13.00 | 13.84 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.35 | 0.27 | 0.25 | 0.24 | 0.21 | 0.18 | 0.16 | 0.13 |
Cash ROIC |
— | (19.63%) | (19.08%) | (20.15%) | (14.84%) | (18.07%) | (36.56%) | (27.07%) | (26.46%) |
Accounts Receivable Turnover |
— | 5.88 | 7.17 | 7.69 | 8.23 | 8.25 | 7.39 | 7.33 | 7.91 |
Accounts Payable Turnover |
— | 8.84 | 8.67 | 7.94 | 6.59 | 6.08 | 6.50 | 7.90 | 7.79 |
Inventory Turnover |
— | 9.72 | 10.21 | 10.48 | 9.34 | 9.77 | 11.05 | 10.22 | 10.01 |
Average Days of Payables |
— | 43.51 | 40.04 | 51.06 | 64.43 | 60.58 | 54.92 | 40.37 | 54.93 |
Days of Inventory on Hand |
— | 35.29 | 35.65 | 33.22 | 48.00 | 30.35 | 37.35 | 36.02 | 38.31 |
Average Receivables |
— | 127.00 | 108.57 | 106.40 | 113.17 | 121.70 | 142.00 | 150.21 | 147.16 |
Average Payables |
— | 44.00 | 44.18 | 47.20 | 62.63 | 73.50 | 72.59 | 63.07 | 66.53 |
Average Inventory |
— | 40.00 | 37.50 | 35.74 | 44.19 | 45.72 | 42.73 | 48.74 | 51.77 |
Average Assets |
— | 1,354.29 | 2,644.63 | 2,670.98 | 2,775.39 | 2,953.60 | 3,124.06 | 3,101.03 | 3,167.42 |
Average Common Equity |
— | (299.50) | (297.82) | (93.28) | 520.34 | 468.17 | 396.99 | 424.32 | 505.47 |
Columns are period end dates